Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3278579
Max Phase: Preclinical
Molecular Formula: C46H73N13O12
Molecular Weight: 1000.17
Molecule Type: Small molecule
Associated Items:
ID: ALA3278579
Max Phase: Preclinical
Molecular Formula: C46H73N13O12
Molecular Weight: 1000.17
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC)NC(=O)[C@@H]1CCC(=O)N1
Standard InChI: InChI=1S/C46H73N13O12/c1-7-29(54-40(66)30-17-18-36(62)53-30)39(65)51-26(6)38(64)58-34(23-60)43(69)57-33(22-27-13-15-28(61)16-14-27)41(67)52-25(5)37(63)56-32(21-24(3)4)42(68)55-31(11-9-19-50-46(47)48)45(71)59-20-10-12-35(59)44(70)49-8-2/h13-16,24-26,29-35,60-61H,7-12,17-23H2,1-6H3,(H,49,70)(H,51,65)(H,52,67)(H,53,62)(H,54,66)(H,55,68)(H,56,63)(H,57,69)(H,58,64)(H4,47,48,50)/t25-,26+,29+,30+,31+,32+,33+,34+,35+/m1/s1
Standard InChI Key: RATOTYBBBQMYNO-VSGOQRDFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1000.17 | Molecular Weight (Monoisotopic): 999.5502 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Humphries J, Wan YP, Folkers K.. (1977) Inhibition of the activity of the luteinizing hormone-releasing hormone (LH-RH) by analogues with variations at positions 2, 3, and 6 and the carboxyl terminus., 20 (7): [PMID:327068] [10.1021/jm00217a024] |
Source(1):